The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Importance Persons with immune dysfunction have a higher risk for severe COVID-19
outcomes. However, these patients were largely excluded from SARS-CoV-2 vaccine …

Background Persons living with diagnosed HIV (PLWDH) are at increased risk for severe
illness due to COVID-19. The degree to which this due to HIV infection, comorbidities, or …

Limited data exists on the effectiveness of a third COVID-19 vaccine dose in solid organ
transplant recipients. We conducted a population-based cohort study using linked …

Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …

Background: Understanding the spectrum of COVID-19 in people with HIV (PWH) is critical
to provide clinical guidance and risk-reduction strategies. Setting: CNICS, a US multisite …

Introduction: Scaling up vaccination against COVID-19 is central to controlling the COVID-19
epidemic in the United States. Several vaccines are now approved for the prevention of …

Objectives Solid organ transplant recipients (SOTR) receiving post‐transplant
immunosuppression show increased COVID‐19‐related mortality. It is unclear whether an …

Background Effective disease surveillance, including that for COVID-19, is compromised
without a standardised method for categorising the immunosuppressed as a clinical risk …

Background People with human immunodeficiency virus (HIV)(PWH) may be at increased
risk for severe coronavirus disease 2019 (COVID-19) outcomes. We examined HIV status …